Knuff & Co LLC Acquires 512 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Knuff & Co LLC increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.9% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,226 shares of the company’s stock after purchasing an additional 512 shares during the quarter. Knuff & Co LLC’s holdings in GE HealthCare Technologies were worth $866,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Osaic Holdings Inc. increased its position in shares of GE HealthCare Technologies by 29.5% during the first quarter. Osaic Holdings Inc. now owns 168,414 shares of the company’s stock valued at $15,282,000 after buying an additional 38,352 shares during the period. Ameritas Investment Partners Inc. increased its holdings in GE HealthCare Technologies by 1.4% during the 1st quarter. Ameritas Investment Partners Inc. now owns 17,803 shares of the company’s stock worth $1,618,000 after acquiring an additional 248 shares during the period. O Shaughnessy Asset Management LLC lifted its stake in GE HealthCare Technologies by 19.1% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 16,090 shares of the company’s stock worth $1,463,000 after purchasing an additional 2,577 shares in the last quarter. UniSuper Management Pty Ltd boosted its holdings in GE HealthCare Technologies by 282.9% in the 1st quarter. UniSuper Management Pty Ltd now owns 15,193 shares of the company’s stock valued at $1,381,000 after purchasing an additional 11,225 shares during the period. Finally, Lake Street Advisors Group LLC purchased a new position in shares of GE HealthCare Technologies during the 1st quarter valued at $211,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Price Performance

GEHC opened at $82.72 on Tuesday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The stock’s 50 day simple moving average is $88.65 and its 200 day simple moving average is $83.55. The firm has a market cap of $37.79 billion, a price-to-earnings ratio of 22.73, a PEG ratio of 2.93 and a beta of 1.24. GE HealthCare Technologies Inc. has a 1 year low of $66.39 and a 1 year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. During the same quarter last year, the business earned $0.99 earnings per share. The business’s revenue was up .9% on a year-over-year basis. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date of this dividend was Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.30%.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have weighed in on GEHC shares. JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Stifel Nicolaus raised their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Wednesday, September 18th. Finally, Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.